Stephan Christgau

Partner, Seed Investments at Novo Holding A/S

Stephan Christgau

Stephan Christgau

Partner, Seed Investments at Novo Holding A/S

Overview
Career Highlights

Osteologix, Inc. (Inactive)
Osteologix Holdings Plc
Lysogene SA

RelSci Relationships

618

Number of Boards

16

Birthday

1965

Age

54

Relationships
RelSci Relationships are individuals Stephan Christgau likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Novo Ventures

Relationship likelihood: Strong

Chief Executive Officer at Insusense ApS

Relationship likelihood: Strong

Principal, Seed Investments at Novo Holding A/S

Relationship likelihood: Strong

Managing Partner Seed Investments at Novo Holding A/S

Relationship likelihood: Strong

Partner, Life Sciences at IP Group Plc

Relationship likelihood: Strong

Founder at Lysogene SA

Relationship likelihood: Strong

Chief Executive Officer & Director at Adenium Biotech ApS

Relationship likelihood: Strong

Chief Executive Officer at Forendo Pharma Oy

Relationship likelihood: Strong

Founder at Galecto Biotech ApS

Relationship likelihood: Strong

Managing Partner at Sofinnova Partners SAS

Relationship likelihood: Strong

Paths to Stephan Christgau
Potential Connections via
Relationship Science
You
Stephan Christgau
Partner, Seed Investments at Novo Holding A/S
Education
PhD

For almost two centuries DTU, Technical University of Denmark, has been dedicated to fulfilling the vision of H.C. Ørsted – the father of electromagnetism – who founded the university in 1829 to develop and create value using the natural sciences and the technical sciences to benefit society. Today, DTU is ranked as one of the foremost technical universities in Europe, continues to set new records in the number of publications, and persistently increase and develop our partnerships with industry, and assignments accomplished by DTU’s public sector consultancy.

Career History
Senior Partner
2007 - Current

Novo Seeds is an active manager which provides funding for seed and early-stage capital requirements, as well as providing management support. The firm invests in startups from Northern Europe operating in the health technology and health services sector, and industries such as biotechnology and medical specialties.

Investment Director
2007 - Current

Novo Ventures is an active manager which provides funding for early and later-stage capital requirements, and provides management support. The firm invests in both public and private companies from Northern Europe and the United States. Novo Ventures targets companies operating in the health technology and health services sector, and industries such as biotechnology and medical specialties. It looks to take minority stake positions in its investments, as well as a seat on the board.

Partner, Seed Investments
Current

Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation's assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.

Boards & Committees
Chairman
2010 - Prior

Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark.

Director
Prior

EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark.

Director
Prior

Inagen ApS is a holding company that develops novel biopharmaceuticals for anti-viral treatment opportunities. Its primary candidate is treatment for Cytomegalovirus (CMV). The technology utilizes a \"self targeting capability\", which takes place in the natural defense mechanism of the specific disease, to target and kill infected cells. Its platform technology can be utilized to target numerous infectious diseases. The company was founded by Thomas Nitschke Kledal l in 2007 and is headquartered in Lyngby, Denmark.

Member, Committee on Exploratory Pre-Seed Grants
Prior - 2015

Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Stephan Christgau. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Stephan Christgau's profile does not indicate a business or promotional relationship of any kind between RelSci and Stephan Christgau.